MediRite (Pty) Ltd., a prominent player in the South African healthcare sector, is headquartered in ZA and operates extensively across the nation. Founded in 1997, the company has established itself as a trusted provider of pharmaceutical and healthcare products, catering to the diverse needs of its customers. Specialising in retail pharmacy services, MediRite offers a unique blend of convenience and quality, with a focus on affordable healthcare solutions. Their extensive range of products includes prescription medications, over-the-counter drugs, and health-related services, setting them apart in a competitive market. Recognised for their commitment to customer care and innovation, MediRite has achieved significant milestones, including numerous awards for service excellence. With a strong market position, the company continues to enhance its offerings, ensuring that quality healthcare is accessible to all South Africans.
How does MediRite (Pty) Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
MediRite (Pty) Ltd.'s score of 53 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
MediRite (Pty) Ltd., headquartered in South Africa (ZA), currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Shoprite Holdings Ltd., which cascades its emissions data and climate commitments down to MediRite. As such, any climate-related targets or achievements would be derived from the parent company's initiatives. MediRite has not publicly outlined specific reduction targets or commitments under the Science Based Targets initiative (SBTi) or other climate pledges. The absence of documented reduction initiatives suggests that the company may still be in the early stages of formalising its climate strategy. As part of the Shoprite Holdings Ltd. corporate family, MediRite may benefit from broader sustainability efforts and performance metrics established by its parent organisation. However, without specific emissions data or reduction targets, it is challenging to assess the company's individual climate impact or commitments at this time.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Scope 1 | 600,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 1,867,528,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 3 | 16,249,912,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
MediRite (Pty) Ltd.'s Scope 3 emissions, which decreased by 1% last year and decreased by approximately 12% since 2021, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Use of Sold Products" being the largest emissions source at 67% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
MediRite (Pty) Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.